Posted on 11/5/20
BioDelivery Sciences Reports Strong Q3 2020 Results
RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
Outlook Therapeutics Secures $10 Million
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg
Posted on 11/5/20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies . . .
Posted on 11/5/20
Harvard Bioscience Announces Third Quarter 2020 Financial Results
HOLLISTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced financial results for the three and nine months ended September 30, . . .
Posted on 11/5/20
Cyclerion Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Updates
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of . . .
Posted on 11/5/20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
Posted on 11/5/20
Kymera Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
WATERTOWN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein . . .
Posted on 11/5/20
Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy . . .
Posted on 11/5/20
VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
BRIDGEWATER, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/5/20
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
EWING, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS), a pharmaceutical technology company, today reported financial and operating results for the third . . .
Posted on 11/5/20
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CRANBURY, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for . . .
Posted on 11/5/20
Biogen Changes The World And Grows 44%
SummaryBiogen had a dramatic day, after years of flip-flop, as it appears the company's new Aducanumab drug will be approved.Even outside of Aducanumab, the company has . . .
Posted on 11/5/20
BioDelivery Sciences Announces $25 Million Share Repurchase Program
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
Here's What's Behind Bristol Myers Squibb's Huge Acquisitions
The pharmaceutical industry is famous for generating enormous profits with help from patent-protected exclusivity, but those protections don't last forever. In order to produce steadily growing . . .
Posted on 11/5/20
3 Big Advantages Novavax Has Over Moderna
Moderna (NASDAQ:MRNA) just might win FDA emergency use authorization for its COVID-19 vaccine candidate mRNA-1273 by the end of the year. Only one other coronavirus vaccine . . .
Posted on 11/5/20
Is Novavax Stock a Buy?
With just a couple of months left in the year, all eyes are on companies working to develop a vaccine for COVID-19. A reliable preventive method . . .
Posted on 11/5/20
Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia
Novavax (NASDAQ:NVAX) announced on Wednesday that it has reached an agreement to provide the Australian government with 40 million doses of its COVID-19 vaccine candidate, NVX-CoV2373, . . .
Posted on 11/5/20
3 Big Advantages Novavax Has Over Moderna
Moderna (NASDAQ:MRNA) just might win FDA emergency use authorization for its COVID-19 vaccine candidate mRNA-1273 by the end of the year. Only one other coronavirus vaccine . . .
Posted on 11/5/20
BioDelivery Sciences Announces $25 Million Share Repurchase Program
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
G1 Therapeutics Provides Financial Update
RESEARCH TRIANGLE PARK, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a corporate and financial update . . .
Posted on 11/5/20
Stealth BioTherapeutics Announces Development Financing
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced . . .
Posted on 11/4/20
Behavioral Health Group Acquires Wellness Ambulatory Care
Responding to the continued public health crisis of opioid addiction in the US, Behavioral Health Group (BHG), the largest network of Joint Commission-accredited outpatient opioid treatment . . .
Posted on 11/4/20
AdaptHealth Announces Third Quarter 2020 Financial Results
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .
Posted on 11/4/20
Rocket Pharmaceuticals Reports Third Quarter 2020 Financial Results
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial . . .
Posted on 11/4/20
Conversion Labs Close $15 Million Private Placement
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 . . .

